-
Mashup Score: 0Screening Reduces Symptom Burden in Pediatric Cancer Patients - Oncology Nurse Advisor - 13 day(s) ago
Study results “provide strong support for integrating symptom screening and care pathways into routine clinical care,” according to researchers
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2
Combination treatment with retifanlimab, bevacizumab, and hypofractionated radiotherapy — with or without epacadostat — warrants further investigation, according to researchers.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Treatment with retifanlimab, bevacizumab, and hypofractionated radiotherapy — with or without epacadostat — appears safe and effective in patients with recurrent #glioblastoma. Presented at #SNO24, reported by @CancerTherAdvsr. https://t.co/Laz19EO6Av
-
-
Mashup Score: 0Surveillance for Cutaneous Malignant Neoplasms Recommended in Post-BMT Patients - Oncology Nurse Advisor - 14 day(s) ago
Researchers explored the risks for basal cell carcinoma, squamous cell carcinoma, and melanoma in patients who underwent BMT.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Patients who have undergone BMT are at significant risk of developing cutaneous #malignantNeoplasms, necessitating close posttransplant surveillance. Published in @JAMADerm. https://t.co/CfpKYdXkxU
-
-
Mashup Score: 0Prevalence of Psychiatric Disorders High in Patients With Breast Cancer - Oncology Nurse Advisor - 16 day(s) ago
Researchers investigated the prevalence of psychiatric disorders and need for psycho-oncology support among patients with breast cancer.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
A significant proportion of patients with #breastcancer have comorbid #psychiatricDisorders and receive psycho-oncology support and/or psychiatric therapies. Published in @CBCjournal. https://t.co/XXMFPBYru5
-
-
Mashup Score: 0Robotic Partial Cystectomy Safe After Neoadjuvant Chemotherapy for MIBC - Oncology Nurse Advisor - 17 day(s) ago
Small retrospective study showed that the procedure achieved negative surgical margins in all cases, with no patients requiring salvage cystectomy.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Robot-assisted partial cystectomy following neoadjuvant chemotherapy for muscle-invasive #bladdercancer is a safe procedure, investigators concluded in a presentation at @UroOnc #URO24. https://t.co/dfY8arFGP6 #MIBC
-
-
Mashup Score: 0Serum Lipid Profiles May Have Diagnostic Utility in Gastric Cancer - Oncology Nurse Advisor - 19 day(s) ago
Researchers investigated the diagnostic value of assessing serum lipid profiles and insulin resistance markers for gastric cancer.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Serum lipid profiles may improve the diagnostic precision for #gastricCancer and predict side effects from chemotherapy. https://t.co/ehWtL9XO0z
-
-
Mashup Score: 1Olaparib, Bevacizumab Combination Safe in Older Patients With Ovarian Cancer - Oncology Nurse Advisor - 19 day(s) ago
Adding olaparib to bevacizumab was safe with good quality of life in older patients with advanced ovarian cancer.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The addition of olaparib to bevacizumab is safe among older patients with #ovarianCancer. Published in @OncJournal. https://t.co/YWiu6G0ZxP #gyncsm
-
-
Mashup Score: 0Addressing Tumor-Specific Training Needs of the CNS in Uro-Oncology - Oncology Nurse Advisor - 21 day(s) ago
A discussion paper on the role of the clinical nurse specialist in uro-oncology noted challenges due to a lack of consistent definition of the role, tumor-specific training, and nurse workforce issues.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Therapies for #kidneycancer have transformed treatment pathways, extending survival and improving outcomes; yet the role of the clinical nurse specialist in uro-oncology remains undervalued and underdeveloped. Published in @SemOncNurs. https://t.co/hBaKwsKzvO #kcsm #uroOnc
-
-
Mashup Score: 0
Researchers sought to assess whether nilotinib and dasatinib would have similar efficacy in patients with CML in chronic phase.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Nilotinib and dasatinib appear to offer similar efficacy for inducing MR4.5 among patients with de novo chronic myeloid #leukemia in chronic phase. Published in @BloodAdvances and @HematologyAdv. https://t.co/XWRbrxdJod #CML
-
-
Mashup Score: 0“Unprecedented Efficacy” Seen With Teclistamab Maintenance in Multiple Myeloma - Oncology Nurse Advisor - 23 day(s) ago
Researchers are now comparing teclistamab plus lenalidomide to teclistamab alone and lenalidomide alone.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Teclistamab maintenance, given alone or in combination with lenalidomide, appeared to be safe and demonstrated “unprecedented efficacy” in patients with #multipleMyeloma in the phase 3 MajesTEC-4 trial. Presented at #ASH24 by @CancerTherAdvsr. https://t.co/7UNH5KG6iq
-
Regular symptom screening in patients with #pediatricCancer can lead to a reduced symptom burden, according to a pair of studies published in @JAMAPediatrics, @JAMA_current, and @CancerTherAdvsr. https://t.co/14SQ03m8wB #pedonc